Press release
Cross-Subsidization To See The Light Of The Day At Injectable Drug Delivery Market
The global injectable drug delivery market was valued at US$ 30.5 Bn in 2018, and is expected to exhibit a CAGR of around 9% during the forecast period (2019-2029).
Strategizing The Moves For The Next Decade? See Through Sample Of Injectable Drug Delivery Market Report! https://www.persistencemarketresearch.com/samples/3774
Company Profiles
Eli Lilly and Company
Biocon
Becton, Dickinson & Company
West Pharmaceutical Services, Inc.
Johnson & Johnson
Antares Pharma
AbbVie Inc.
Pfizer Inc.
Mylan N.V.
Vetter Pharma-Fertigung GmbH & Co.KG
Emperra GmbH
Starting With The New Decade On A Diligent Note In The Injectable Drug Delivery Market? https://www.persistencemarketresearch.com/methodology/3774
Key Takeaways of Injectable Drug Delivery Market Study
Insulin pens contributed the most share to the injectable drug delivery market in 2018, due to the rising prevalence of diabetes in developing countries.
Non-smart injector technology accounted for a prominent share in the global injectable drug delivery market in 2018, due to increase in the adoption of advanced technology and rising demand for smartphone-integrated products.
Rise in the demand for connected devices and the high cost of such devices offer growth opportunities for manufacturers of reusable injectable drug delivery devices.
Diabetes indication is expected to continue to hold a prominent position in the injectable drug delivery market throughout the forecast period.
Increase in the number of pharmaceutical manufacturers has contributed to the dominance of North America in the global injectable drug delivery market.
Attributed to growing awareness regarding various diseases such as cancer and diabetes, East Asia is expected to register notable growth opportunities for the injectable drug delivery market.
"Smart injectable drug delivery devices not only improve patient compliance to treatment but also collect extensive data that is valuable for future research. Rising demand for connected injectable drug delivery devices will offer significant growth opportunity for the injectable drug delivery market," says a PMR analyst.
Trends in Smart Injectable Drug Delivery Technologies
There are many research and pipeline products that will have the ability to connect with smartphones and trackers. However, current smart products are predominantly available as reusable devices. This is attributed to the current state of technology that requires further advancements to apply to disposable products. According to a number of studies and key opinion leaders in the industry, there are a number of factors that limit disposable injectable drug delivery devices from being integrated with smart/connecting technologies. Some of these factors include high cost of Bluetooth integration, low range connectivity with NFC, and lack of power source for connectivity. Thus, although disposable injectable drug delivery will continue holding a larger share throughout the forecast period, reusable injectable drug delivery devices have the potential to grow at a relatively faster rate, at least in the first five years of the forecast period.
How About Obtaining Insights About The Region To Enter Concerning The Injectable Drug Delivery Market? Press The "Purchase Now" Button To Have Our Injectable Drug Delivery Market Report! https://www.persistencemarketresearch.com/checkout/3774
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About Us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cross-Subsidization To See The Light Of The Day At Injectable Drug Delivery Market here
News-ID: 2714322 • Views: …
More Releases from Persistence Market Research
Brewer's Yeast Powder Market Value to Reach US$4.4 Bn by 2031 Driven by Rising H …
The global brewer's yeast powder market is set to experience strong growth over the coming years, expanding from a valuation of US$2.5 billion in 2024 to US$4.4 billion by the end of 2031. This growth represents a robust compound annual growth rate (CAGR) of 8.4% during the forecast period from 2024 to 2031. The rising demand for functional food ingredients, growing health consciousness among consumers, and the expanding applications of…
Asparagus Market Growth Driven by Health Trends to Reach US$33.8 Bn by 2030 at 5 …
The global asparagus market is forecast to expand at a steady CAGR of 5.2%, increasing from a value of US$23.7 billion in 2023 to US$33.8 billion by the end of 2030. This growth trajectory is underpinned by the rising global demand for nutrient-rich vegetables and the expanding application of asparagus in culinary and functional food products. The growing health-conscious consumer base, combined with an increasing preference for plant-based and low-calorie…
Flat Glass Market Valued at US$ 213.0 Billion in 2025, Projected to Reach US$ 32 …
The global flat glass market has become one of the fastest-growing sectors in the materials industry, driven by its wide range of applications across construction, automotive, and renewable energy sectors. Flat glass, also known as sheet glass, is produced in large, flat sheets and can be processed further into laminated, tempered, or coated forms for enhanced performance. Its versatility, transparency, and strength make it an essential material for modern architectural…
Essential Oils Market Value to Reach US$39.1 Bn by 2031 Driven by Rising Demand …
The global essential oils market is witnessing robust expansion, with the market size valued at US$20.6 billion in 2024 and projected to reach US$39.1 billion by 2031. This growth represents a significant compound annual growth rate (CAGR) of 7.7% during the forecast period from 2024 to 2031. The increasing consumer inclination toward natural and organic products, coupled with the rising adoption of aromatherapy and natural ingredients across personal care, food…
More Releases for Injectable
Key Small Molecule Injectable Drugs Market Trend for 2025-2034: Small Molecule I …
What Is the Future Outlook for the Small Molecule Injectable Drugs Market's Size and Growth Rate?
The small molecule injectable drugs market has grown rapidly in recent years. It will rise from $219.57 billion in 2024 to $248.2 billion in 2025, at a CAGR of 13.0%. The growth is attributed to the rising prevalence of chronic diseases, an aging population, government initiatives, increased healthcare spending, and improvements in manufacturing processes.
The small…
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Facial Injectable Market Size to Hit $7.5 Billion by 2028 | Facial Injectable In …
According to our experience research team, Facial Injectable Market was valued at USD 4.4 Billion in 2021, and the global Facial Injectable industry is projected to reach a value of USD 7.5 Billion by 2028, at a CAGR of 9.4% during the forecast period 2022-2028
The report is focused on gaining various Facial Injectable market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining the market growth. Further, the global…
Small-Molecule Injectable Market
The global Small-Molecule Injectable Market was valued at US$ 55.8 Bn in 2020. Expanding at a 7.3% CAGR, the market valuation is expected to top US$ 112.9 Bn by 2031, finds ESOMAR-certified consulting firm Future Market Insights (FMI) in a recent market analysis.
The COVID-19 pandemic outbreak has sparked efforts to repurpose already-approved medicines for treatment. Several clinical studies are now being conducted on different antiviral medicines and small-molecule injectables that…
Global Injectable Drug Delivery Devices Market | Global Injectable Drug Delivery …
The injectable drug delivery devices market involves of sales of conventional syringes, needle-free injectors, auto injectors and pen injectors. The market contains the sales of the Injectable devices that have been comprehensively utilized for several routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular and several others to cure the medical conditions vacillating from cancer to autoimmune disorders. The injectable drug delivery devices utilized in hospitals, clinics…
Ioversol Market Report 2018: Segmentation by Type (Ioversol 34% Injectable Solut …
Global Ioversol market research report provides company profile for China Resources Pharmaceutical (Shanghai) Co, HB Ocean, Novalek Pharmaceuticals Pvt. Ltd, Stellence Pharmscience Pvt. Ltd, A.S. Joshi & Company, Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co, Mallinckrodt Pharmaceuticals, Ultraject and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of…
